| Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.080 | AlteredExpression | disease | BEFREE | Research is lacking on the role of AREG in invasive breast cancer and the co-expression with androgen receptor (AR) status. | 31040043 | 2019 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | Expression of Androgen Receptor and Cancer Stem Cell Markers (CD44<sup>+</sup>/CD24<sup>-</sup> and ALDH1<sup>+</sup>): Prognostic Implications in Invasive Breast Cancer. | 29843115 | 2018 | ||||
|
0.080 | Biomarker | disease | BEFREE | The potential impact of androgens on mammary carcinogenesis has been studied in recent years, and several authors have proposed androgen receptor (AR) IHC testing and targeted antiandrogenic therapy in patients with locally advanced or metastatic triple-negative invasive breast cancer (ie, negative for ER and progesterone receptor and HER-2). | 29489512 | 2018 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | Androgen receptor (AR) is an important transcriptional factor, which is frequently expressed in invasive breast cancer and correlates patients' prognosis. | 29423076 | 2018 | ||||
|
0.080 | Biomarker | disease | BEFREE | Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population? | 29651273 | 2018 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | Immunohistochemical AR expression was assessed in 910 women with invasive breast cancer diagnosed 1991-2010, supplemented with clinicopathological information, vital status, and cause of death, with the last follow-up in December 2014 (median 10 years). | 28643022 | 2017 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis. | 27514395 | 2016 | ||||
|
0.080 | GeneticVariation | disease | BEFREE | We successfully determined both AR CAG(n) and VDR A(n) genotype in 1,502 women with invasive breast cancer and in 1,510 control women. | 17855696 | 2007 |